Brand & Commercial Strategy
Key pharma imperatives
Today’s global brands face a challenging world: fierce competition, increased erosion from generic medicines and reduced flexibility on pricing. At the same time, they must contribute higher growth to close gaps in portfolios due to patent expiries and limited pipelines. Consider the imperative to:
- Make brands more productive
- Expand to pharmerging markets
- Ensure brand/commercial operations are future-fit for evolving markets
IMS Consulting Group has developed innovative analytics, with the power to link a broad range of customer data to drive unique, higher-value brand strategies. And, our groundbreaking analysis of New Commercial Models in the leading developed markets offers a comprehensive framework to help clients transform their commercial models by country and therapy area.
Want to accelerate your brand performance? Learn more about our Brand Strategy expertise.
Need help to align and optimize your commercial assets? Learn more about our skills in Commercial Optimization.